HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Monday, 23 July 2012

Recent CUAs

Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers.  35 papers were listed this time. Here's a few in our areas of research interest:

Latimer NR, Bhanu AC, Whitehurst DG. Inconsistencies in NICE guidance for acupuncture: reanalysis and discussion. Acupunct Med. 2012 Jul 3. [Epub ahead of print] PubMed PMID: 22759903.

Nguyen CM, Bounthavong M, Mendes MA, et al Cost Utility of Tumour Necrosis Factor-α Inhibitors for Rheumatoid Arthritis: An Application of Bayesian Methods for Evidence Synthesis in a Markov Model. Pharmacoeconomics. 2012 Jul 1;30(7):575-93. PubMed PMID: 22640174.

Palmer AJ, Tucker DM. Cost and clinical implications of diabetes prevention in an Australian setting: a long-term modeling analysis. Prim Care Diabetes. 2012 Jul;6(2):109-21. Epub 2011 Dec 6. PubMed PMID: 22153888.

Granström O, Bergenheim K, McEwan Pet al. Cost-effectiveness of saxagliptin (Onglyza®) in type 2 diabetes in Sweden. Prim Care Diabetes. 2012 Jul;6(2):127-36. Epub 2011 Oct 15. PubMed PMID: 22001114.